About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials | 7,492 Studies Recruiting

Clinical TrialsProstate Cancer

Prostate Cancer Clinical Trials

Browse 7,492 clinical trials for prostate cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 961-980 of 7,492 trials

RecruitingEffectiveness of Focal Therapy in Men With Prostate CancerIn the Netherlands, most men with prostate cancer (PCa) are treated with radical whole-gland treatment, i.e. prostatectomy or radiotherapy.NCT06223295·Nijmegen, Gelderland and 4 others CompletedEffectiveness of Care in Certified Cancer Centres in GermanyAssessment of the effectiveness of care in certified cancer centres for eight cancer entities via a retrospective cohort study based on secondary data from statutory health…NCT04334239·Dresden, Saxony

Related Searches

prostate carcinomatrials

Data from ClinicalTrials.govTerms

TerminatedFerumoxtran-10-enhanced MRI in Prostate Cancer PatientsThis will be a confirmatory, prospective, open-label, single-arm, reader-blinded, multi-centre phase 3 study to assess the diagnostic accuracy and safety of Ferrotran®-enhanced…NCT04261777·Ghent and 14 others

CompletedQuality of Life and Supportive Care Preferences Following Radiation Therapy in Prostate Cancer SurvivorsThis pilot clinical trial studies quality of life and supportive care preferences following radiation therapy in prostate cancer survivors.NCT02704377·Columbus, Ohio

CompletedPSMA Expression and PSMA PET Imaging in Soft Tissue Sarcomas and Urothelial Cell CarcinomasThis pilot study aims to investigate the PSMA expression in the biopsy material of advanced soft tissue sarcomas and advanced urothelial cell carcinomas, and in case of high PSMA…NCT05522257·Leiden

CompletedCabozantinib and Abiraterone With Checkpoint Inhibitor Immunotherapy in Metastatic Hormone Sensitive Prostate Cancer (CABIOS Trial)The goal of this study is to determine the recommended phase 2 dose of the multi-drug combination of abiraterone, cabozantinib, and nivolumab in conjunction with ongoing androgen…NCT04477512·St Louis, Missouri

UnknownDeterminants of Quality Of Life in AGEd Cancer PatientsPatients face multiple stresses and challenges in the aftermath of cancer diagnosis.NCT02672657·Créteil and 2 others

CompletedMetformin for Rising PSA Remote TrialClinical trials are critical to informing the care of patients with cancer. However, only 3-5% of patients with cancer enroll in clinical trials.NCT02376166·New York, New York

CompletedMicro RNAs to Predict Response to Androgen Deprivation TherapyIdentify exosomal micro RNA that predict responses to ADTNCT02366494·Milwaukee, Wisconsin

CompletedThalidomide and Doxil® in Patients With Androgen Independent Prostate Cancer (AIPC)The primary objective of this study is to evaluate PSA response rates of the combination of Doxil and Thalidomide in patients with AIPC who have failed chemotherapy.NCT00307294·Pittsburgh, Pennsylvania

UnknownConformal Radiotherapy (CRT) Alone Versus CRT Combined With HDR BT or Stereotactic Body Radiotherapy for Prostate CancerThe purpose of this study is to compare the outcomes of conventionally fractionated conformal radiotherapy with CF-CRT combined with either high-dose-rate brachytherapy or…NCT01839994·Gliwice, Silesian Voivodeship

UnknownCardiovascular Events in GnRH Agonist vs. AntagonistThe purpose of this study is to test if the use of Degarelix for 1 year associated with a lower rate of cardiovascular toxicity compared to Gonadotropin-releasing hormone (GnRH)…NCT04182594·Petah Tikva

RecruitingA Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate CancerHormone therapy, or androgen deprivation therapy (ADT) is a standard way to treat prostate cancer.NCT07005154·Huntsville, Alabama and 53 others

WithdrawnPerioperative Atezolizumab With MVA-BN-Brachyury and PROSTVAC For Intermediate-Risk And High-Risk Localized Prostate CancerThis study is a prospective, open label, single arm phase II trial.NCT04020094·Salt Lake City, Utah

UnknownMechanical Nerve Stimulation in the Treatment of Post Prostatectomy IncontinenceDuring transcutaneous mechanical nerve stimulation in spinal cord injured men an increase in pressure was observed in the external urethral sphincter along with an increase in…NCT01540656·Copenhagen and 1 other

Active not recruitingAn Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)This Phase II study aims to evaluate efficacy and safety of the combination of JSB462 (also known as luxdegalutamide) at 100 mg and 300 mg once a day (QD) doses + abiraterone…NCT06991556·La Jolla, California and 65 others

CompletedIntensity Modulated Radiation Therapy for Prostate CancerBACKGROUND: -This study represents a progression from findings in four previous National Cancer Institute (NCI) Radiation Oncology Branch (ROB) protocols (02-C-0167A, 02-C-0207E…NCT00214422·Bethesda, Maryland

RecruitingA Clinical Study of [68Ga]Ga-ELI421 Injection PET Imaging in Patients With Prostate CancerPrimary Objective: To evaluate the safety and tolerability of PET imaging following a single intravenous infusion of \[⁶⁸Ga\]Ga-ELI421 injection in patients with prostate cancer.NCT07689656·Wuhan, Hubei

RecruitingA Study of [177Lu]Lu-A9-0631 and [225Ac]Ac-A9-0642 With [68Ga]Ga-A9-6217 or [177Lu]Lu-A9-0631 Imaging in GRPR+ Solid TumorsThis is a Phase 1-1b multicenter clinical study to evaluate the safety, efficacy, and dosimetry of \[177Lu\]Lu-A9-0631 and \[225Ac\]Ac-0642 in participants with Gastrin-Releasing…NCT07661641·Melbourne N., Victoria and 1 other

RecruitingAndrogen Ablation Therapy With or Without Niraparib After Radiation Therapy for the Treatment of High-Risk Localized or Locally Advanced Prostate CancerThis phase II trial studies the effect of androgen ablation therapy with or without niraparib after standard of care radiation therapy in treating patients with prostate cancer…NCT04947254·Houston, Texas

PreviousPage 49 of 375Next